Mary Hayden
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aedes | 17 | 2023 | 57 | 2.100 |
Why?
| Dengue | 12 | 2023 | 69 | 2.060 |
Why?
| Mosquito Control | 8 | 2020 | 27 | 1.880 |
Why?
| Insect Vectors | 6 | 2018 | 27 | 1.660 |
Why?
| Health Knowledge, Attitudes, Practice | 7 | 2024 | 1275 | 1.230 |
Why?
| Dengue Virus | 5 | 2023 | 41 | 1.110 |
Why?
| Lyme Disease | 2 | 2024 | 50 | 1.090 |
Why?
| Mosquito Vectors | 5 | 2023 | 25 | 1.040 |
Why?
| Disease Outbreaks | 9 | 2021 | 341 | 0.950 |
Why?
| Ticks | 1 | 2024 | 17 | 0.940 |
Why?
| Pets | 1 | 2024 | 25 | 0.920 |
Why?
| Insect Control | 1 | 2018 | 11 | 0.590 |
Why?
| Women | 1 | 2018 | 52 | 0.590 |
Why?
| Community Participation | 2 | 2018 | 125 | 0.590 |
Why?
| Culicidae | 2 | 2015 | 30 | 0.590 |
Why?
| Stakeholder Participation | 1 | 2018 | 77 | 0.550 |
Why?
| Urban Population | 6 | 2024 | 440 | 0.550 |
Why?
| Ownership | 3 | 2024 | 87 | 0.500 |
Why?
| Zika Virus Infection | 3 | 2023 | 154 | 0.470 |
Why?
| Leadership | 1 | 2018 | 356 | 0.440 |
Why?
| Neisseria meningitidis, Serogroup A | 1 | 2013 | 1 | 0.430 |
Why?
| Meningitis, Meningococcal | 1 | 2013 | 6 | 0.430 |
Why?
| Kenya | 5 | 2022 | 107 | 0.410 |
Why?
| Oviposition | 2 | 2016 | 8 | 0.380 |
Why?
| Arizona | 8 | 2023 | 78 | 0.380 |
Why?
| Hot Temperature | 3 | 2020 | 358 | 0.370 |
Why?
| Zika Virus | 2 | 2023 | 117 | 0.360 |
Why?
| Surveys and Questionnaires | 8 | 2024 | 5362 | 0.360 |
Why?
| Microclimate | 1 | 2010 | 4 | 0.340 |
Why?
| Animals | 24 | 2024 | 34479 | 0.340 |
Why?
| Florida | 5 | 2019 | 93 | 0.340 |
Why?
| Mexico | 9 | 2021 | 190 | 0.310 |
Why?
| Insecticide-Treated Bednets | 2 | 2020 | 3 | 0.310 |
Why?
| Indonesia | 2 | 2018 | 21 | 0.300 |
Why?
| Environmental Exposure | 3 | 2020 | 461 | 0.270 |
Why?
| Insecticides | 2 | 2017 | 34 | 0.270 |
Why?
| Housing | 2 | 2022 | 131 | 0.260 |
Why?
| Humans | 34 | 2024 | 128417 | 0.240 |
Why?
| Climate | 3 | 2015 | 87 | 0.240 |
Why?
| Female | 22 | 2024 | 68153 | 0.240 |
Why?
| Tick-Borne Diseases | 1 | 2024 | 9 | 0.240 |
Why?
| Rhode Island | 1 | 2024 | 26 | 0.230 |
Why?
| New York | 1 | 2024 | 124 | 0.230 |
Why?
| Endemic Diseases | 1 | 2024 | 30 | 0.230 |
Why?
| Patient Acceptance of Health Care | 3 | 2022 | 758 | 0.230 |
Why?
| Cats | 1 | 2024 | 209 | 0.230 |
Why?
| Ochlerotatus | 2 | 2014 | 3 | 0.220 |
Why?
| Weather | 4 | 2021 | 34 | 0.220 |
Why?
| Middle Aged | 11 | 2024 | 30889 | 0.220 |
Why?
| Data Collection | 2 | 2018 | 647 | 0.220 |
Why?
| Adult | 13 | 2024 | 35299 | 0.220 |
Why?
| Dogs | 1 | 2024 | 366 | 0.210 |
Why?
| Young Adult | 8 | 2024 | 12312 | 0.210 |
Why?
| Cities | 6 | 2019 | 105 | 0.210 |
Why?
| Aged | 9 | 2024 | 21953 | 0.200 |
Why?
| Plague | 1 | 2023 | 58 | 0.200 |
Why?
| Temperature | 4 | 2023 | 625 | 0.190 |
Why?
| Focus Groups | 1 | 2024 | 452 | 0.190 |
Why?
| Male | 15 | 2024 | 62857 | 0.180 |
Why?
| Rocky Mountain Spotted Fever | 1 | 2021 | 1 | 0.180 |
Why?
| Self Report | 2 | 2022 | 801 | 0.180 |
Why?
| Socioeconomic Factors | 4 | 2018 | 1212 | 0.180 |
Why?
| Communicable Diseases | 1 | 2022 | 144 | 0.170 |
Why?
| Heat-Shock Response | 1 | 2020 | 71 | 0.170 |
Why?
| Altitude | 3 | 2014 | 447 | 0.170 |
Why?
| Adolescent | 9 | 2024 | 20179 | 0.170 |
Why?
| Arbovirus Infections | 1 | 2020 | 19 | 0.170 |
Why?
| Seasons | 5 | 2016 | 497 | 0.170 |
Why?
| Climate Change | 3 | 2021 | 163 | 0.170 |
Why?
| Malaria | 2 | 2020 | 58 | 0.160 |
Why?
| Ghana | 3 | 2015 | 34 | 0.160 |
Why?
| Ecosystem | 2 | 2018 | 562 | 0.160 |
Why?
| Air Pollution, Indoor | 2 | 2019 | 144 | 0.160 |
Why?
| Pupa | 5 | 2018 | 10 | 0.160 |
Why?
| Larva | 5 | 2018 | 211 | 0.150 |
Why?
| Animal Distribution | 1 | 2018 | 21 | 0.150 |
Why?
| West Nile Fever | 2 | 2016 | 49 | 0.150 |
Why?
| Chikungunya Fever | 1 | 2019 | 76 | 0.140 |
Why?
| India | 1 | 2018 | 170 | 0.140 |
Why?
| Pesticides | 1 | 2018 | 58 | 0.140 |
Why?
| Family Characteristics | 4 | 2021 | 179 | 0.140 |
Why?
| Models, Statistical | 2 | 2019 | 621 | 0.140 |
Why?
| Community-Acquired Infections | 1 | 2019 | 152 | 0.140 |
Why?
| Pregnancy Complications, Infectious | 1 | 2021 | 364 | 0.140 |
Why?
| Protective Clothing | 1 | 2016 | 16 | 0.130 |
Why?
| Cross-Sectional Studies | 5 | 2022 | 5039 | 0.130 |
Why?
| Aerosols | 1 | 2017 | 171 | 0.130 |
Why?
| Air Pollution | 2 | 2019 | 214 | 0.130 |
Why?
| Financing, Government | 1 | 2016 | 42 | 0.130 |
Why?
| Environment | 1 | 2017 | 342 | 0.120 |
Why?
| Antibodies, Viral | 1 | 2019 | 601 | 0.120 |
Why?
| West Nile virus | 1 | 2015 | 38 | 0.120 |
Why?
| Rain | 1 | 2015 | 45 | 0.120 |
Why?
| Copepoda | 1 | 2014 | 2 | 0.110 |
Why?
| Cooking | 1 | 2015 | 58 | 0.110 |
Why?
| Pest Control, Biological | 1 | 2014 | 9 | 0.110 |
Why?
| Communicable Disease Control | 1 | 2015 | 70 | 0.110 |
Why?
| Texas | 4 | 2020 | 227 | 0.110 |
Why?
| Epidemics | 1 | 2015 | 82 | 0.110 |
Why?
| Animals, Genetically Modified | 1 | 2015 | 231 | 0.110 |
Why?
| Models, Theoretical | 1 | 2017 | 542 | 0.110 |
Why?
| Pandemics | 1 | 2022 | 1476 | 0.110 |
Why?
| Heat Stress Disorders | 1 | 2014 | 69 | 0.100 |
Why?
| Aged, 80 and over | 4 | 2020 | 7033 | 0.100 |
Why?
| Meningitis | 1 | 2013 | 80 | 0.100 |
Why?
| Seroepidemiologic Studies | 3 | 2020 | 155 | 0.100 |
Why?
| Population Dynamics | 3 | 2019 | 136 | 0.090 |
Why?
| Cost of Illness | 1 | 2013 | 277 | 0.090 |
Why?
| Models, Biological | 2 | 2015 | 1691 | 0.090 |
Why?
| Computer Simulation | 1 | 2015 | 939 | 0.090 |
Why?
| Odds Ratio | 1 | 2013 | 1023 | 0.090 |
Why?
| Population Density | 3 | 2016 | 91 | 0.080 |
Why?
| Ecology | 1 | 2010 | 108 | 0.080 |
Why?
| Research Design | 1 | 2015 | 1036 | 0.080 |
Why?
| Severe Dengue | 1 | 2008 | 10 | 0.070 |
Why?
| Risk Factors | 4 | 2019 | 9704 | 0.070 |
Why?
| Environmental Monitoring | 1 | 2010 | 322 | 0.070 |
Why?
| Culex | 2 | 2016 | 13 | 0.060 |
Why?
| Case-Control Studies | 1 | 2013 | 3328 | 0.060 |
Why?
| Logistic Models | 1 | 2010 | 1974 | 0.060 |
Why?
| Geography | 2 | 2017 | 186 | 0.060 |
Why?
| Medicine, African Traditional | 1 | 2023 | 2 | 0.050 |
Why?
| Uganda | 1 | 2023 | 72 | 0.050 |
Why?
| Infectious Disease Incubation Period | 1 | 2023 | 4 | 0.050 |
Why?
| Trees | 1 | 2023 | 68 | 0.050 |
Why?
| Longitudinal Studies | 1 | 2010 | 2710 | 0.050 |
Why?
| Floods | 1 | 2021 | 17 | 0.050 |
Why?
| Fever | 1 | 2022 | 295 | 0.050 |
Why?
| Africa, Western | 1 | 2020 | 17 | 0.040 |
Why?
| Saint Kitts and Nevis | 1 | 2019 | 1 | 0.040 |
Why?
| Neutralization Tests | 1 | 2019 | 73 | 0.040 |
Why?
| Serologic Tests | 1 | 2019 | 50 | 0.040 |
Why?
| Humidity | 1 | 2019 | 48 | 0.040 |
Why?
| Urban Health | 1 | 2019 | 79 | 0.040 |
Why?
| Epidemiological Monitoring | 1 | 2019 | 49 | 0.040 |
Why?
| Mortality | 1 | 2020 | 307 | 0.040 |
Why?
| Referral and Consultation | 1 | 2023 | 727 | 0.040 |
Why?
| Child, Preschool | 3 | 2021 | 10384 | 0.030 |
Why?
| United States | 3 | 2021 | 13830 | 0.030 |
Why?
| Cymbopogon | 1 | 2016 | 2 | 0.030 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 815 | 0.030 |
Why?
| Universities | 1 | 2019 | 400 | 0.030 |
Why?
| Delivery of Health Care | 1 | 2023 | 895 | 0.030 |
Why?
| Puerto Rico | 1 | 2015 | 52 | 0.030 |
Why?
| Longevity | 1 | 2016 | 149 | 0.030 |
Why?
| Costs and Cost Analysis | 1 | 2016 | 199 | 0.030 |
Why?
| Household Articles | 1 | 2015 | 24 | 0.030 |
Why?
| Infant | 2 | 2021 | 8914 | 0.030 |
Why?
| Immunoglobulin G | 1 | 2019 | 843 | 0.030 |
Why?
| Risk Assessment | 2 | 2014 | 3232 | 0.030 |
Why?
| Ovum | 1 | 2014 | 29 | 0.030 |
Why?
| Global Warming | 1 | 2014 | 26 | 0.030 |
Why?
| Statistics as Topic | 1 | 2015 | 302 | 0.030 |
Why?
| Spatio-Temporal Analysis | 1 | 2014 | 27 | 0.030 |
Why?
| Equipment Design | 1 | 2015 | 518 | 0.030 |
Why?
| Water | 1 | 2016 | 440 | 0.030 |
Why?
| Child | 3 | 2021 | 20655 | 0.020 |
Why?
| Research | 1 | 2015 | 411 | 0.020 |
Why?
| Virus Diseases | 1 | 2014 | 209 | 0.020 |
Why?
| Hospitalization | 1 | 2020 | 2057 | 0.020 |
Why?
| Public Health | 1 | 2015 | 482 | 0.020 |
Why?
| Pilot Projects | 1 | 2014 | 1563 | 0.020 |
Why?
| Pregnancy | 1 | 2021 | 6357 | 0.020 |
Why?
| Incidence | 1 | 2015 | 2616 | 0.020 |
Why?
| Neural Tube Defects | 1 | 2008 | 63 | 0.020 |
Why?
| Cluster Analysis | 1 | 2008 | 478 | 0.020 |
Why?
| Age Factors | 1 | 2014 | 3103 | 0.020 |
Why?
| Quality of Life | 1 | 2015 | 2680 | 0.010 |
Why?
|
|
Hayden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|